Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 2/2014

01-02-2014 | Capsule Commentary

Capsule Commentary on Wilson et al., The Prevalence of Harmful and Hazardous Alcohol Consumption in U.S. Older Adults

Author: Jeffrey L. Jackson, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2014

Login to get access

Excerpt

Alcohol plays an important role in US Society; for many, social functions such as a trip to the ballgame or an evening out would not be complete without a beer or a glass of wine. The perils of alcohol are well known; it’s the leading cause of traffic fatalities in the United States and other health and social consequences of excess alcohol consumption are common. Largely in response to the social consequences of excess drinking, temperance societies have existed worldwide since the 1800s and were able to successfully ban alcohol for several years in many countries including Canada (1901–1924), Iceland (1915–1935), Finland (1919–1932), Norway (1916–1927) and the United States (1919–1933). …
Literature
1.
Wilson SR, Knowles SB, Huang Q, Fink A. The prevalence of harmful and hazardous alcohol consumption in U.S. older adults; Data from the 2005–2008 National Health and Nutrition Examination Survey (NHANES). J Gen Intern Med, doi:10.​1007/​s11606-013-2577-z.
2.
3.
Bradley KA, Kivlahan DR, Williams EC. Brief approaches to alcohol screening: practical alternatives for primary care. J Gen Intern Med 2009;24:881–3.PubMedCentralPubMedCrossRef
4.
McCormick KA, Cochran NE, Back AL, Merrill JO, Williams EC, Bradley KA. How primary care providers talk to patients about alcohol: a qualitative study. J Gen Intern Med 2006;21:966–72.PubMedCentralPubMedCrossRef
5.
Makoul G, Dhurandhar A, Goel MS, Scholtens D, Rubin AS. Communication about behavioral health risks: a study of videotaped encounters in 2 internal medicine practices. J Gen Intern Med 2006;21:698–703.PubMedCentralPubMedCrossRef
Metadata
Title
Capsule Commentary on Wilson et al., The Prevalence of Harmful and Hazardous Alcohol Consumption in U.S. Older Adults
Author
Jeffrey L. Jackson, MD, MPH
Publication date
01-02-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2611-1

Other articles of this Issue 2/2014

Journal of General Internal Medicine 2/2014 Go to the issue

Letter to the Editor

Marijuana Use and Health in Primary Care

Original Research

Directive Counsel and Morally Controversial Medical Decision-Making: Findings from Two National Surveys of Primary Care Physicians

Original Research

A Cross-Sectional Study Examining Australian General Practitioners’ Identification of Overweight and Obese Patients

Capsule Commentary

Capsule Commentary on Turner et al., Chronic Opioid Therapy Risk Reduction Initiative: Impact on Urine Drug Testing Rates and Results

HEALING ARTS

Janet’s Prayer

Innovation and Improvement

Training for Primary Care’s Future
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits